Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jianglai Biotechnology, operating under the brand Jianglai Bio, is a prominent life sciences company based in Shanghai, China, specializing in the development and manufacturing of research reagents. The company is best known for its extensive catalog of over 10,000 ELISA kits, which target a wide variety of proteins across multiple species including humans, mice, rats, and livestock. In addition to ELISA kits, Jianglai Bio provides high-quality antibodies, recombinant proteins, and biochemical assay kits to support global academic and industrial research. Their products are widely utilized in fields such as immunology, oncology, and cell biology, and are frequently cited in peer-reviewed scientific literature. The company maintains a robust e-commerce presence and a global distribution network to serve the international scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiang Lai Biotechnology.